Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|February 3, 2022
EZH2 Inhibitors: The Unpacking RevolutionVera Adema, Simona Colla
Cell Reports. Medicine|February 14, 2023
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translationJuan Jose Rodriguez-Sevilla, Vera Adema, Guillermo Garcia-Manero, et al.
Blood Cancer Discovery|May 6, 2026
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic ApproachesVera Adema, Francesco Pesce, Guillermo Garcia-Manero, et al.
Blood Advances|March 23, 2019
Subclonal STAT3 mutations solidify clonal dominanceCassandra M Kerr, Michael J Clemente, Peter W Chomczynski, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Leukemia|August 6, 2020
Complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Blood Advances|July 20, 2019
Distinct clinical and biological implications of CUX1 in myeloid neoplasmsMai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
Iscience|March 17, 2023
A multimodal analysis of genomic and RNA splicing features in myeloid malignanciesArda Durmaz, Carmelo Gurnari, Courtney E Hershberger, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Pageof 3